Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 446

1.

Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes.

Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, Holl R; DPV-Wiss-Initiative.

Pediatr Diabetes. 2011 Feb;12(1):11-7. doi: 10.1111/j.1399-5448.2010.00650.x.

PMID:
20337978
2.

Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.

Schütt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, Mayer I, Rosenbauer J, Wagner C, Zimmermann A, Kerner W, Holl RW; DPV Initiative.

Exp Clin Endocrinol Diabetes. 2006 Jul;114(7):384-8.

PMID:
16915542
3.

Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes.

Olinder AL, Kernell A, Smide B.

Pediatr Diabetes. 2009 Apr;10(2):142-8. doi: 10.1111/j.1399-5448.2008.00462.x. Epub 2008 Oct 24.

PMID:
19175898
4.
6.
7.

Continuous glucose monitoring systems for type 1 diabetes mellitus.

Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008101. doi: 10.1002/14651858.CD008101.pub2. Review.

PMID:
22258980
8.
10.

Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus.

Skogsberg L, Fors H, Hanas R, Chaplin JE, Lindman E, Skogsberg J.

Pediatr Diabetes. 2008 Oct;9(5):472-9. doi: 10.1111/j.1399-5448.2008.00390.x. Epub 2008 Aug 20.

PMID:
18721168
11.
12.

[Metabolic control in young children with type 1 diabetes treated with continuous subcutaneous insulin infusion (insulin pump)].

Pańkowska E, Lipka M, Wysocka M, Szypowska A, Trippenbach-Dulska H, Czaplińska M, Kołodziejska B.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2003;9(1):11-5. Polish.

PMID:
12831632
13.

Nationwide cross-sectional survey of 3560 children and adolescents with diabetes in Italy.

Vanelli M, Cerutti F, Chiarelli F, Lorini R, Meschi F; MCDC-Italy Group.

J Endocrinol Invest. 2005 Sep;28(8):692-9. Erratum in: J Endocrinol Invest. 2005 Oct;28(9):868.

PMID:
16277164
14.
15.

Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia.

Hanas R, Adolfsson P.

Pediatr Diabetes. 2006 Feb;7(1):25-31. Erratum in: Pediatr Diabetes. 2006 Oct;7(5):298.

PMID:
16489971
16.

Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial.

Lagarde WH, Barrows FP, Davenport ML, Kang M, Guess HA, Calikoglu AS.

Pediatr Diabetes. 2006 Jun;7(3):159-64.

PMID:
16787523
17.

Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes.

Deiss D, Kordonouri O, Hartmann R, Hopfenmüller W, Lüpke K, Danne T.

Pediatr Diabetes. 2007 Jun;8(3):157-62.

PMID:
17550426
18.

Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control study.

Brorsson AL, Viklund G, Örtqvist E, Lindholm Olinder A.

Pediatr Diabetes. 2015 Nov;16(7):546-53. doi: 10.1111/pedi.12209. Epub 2014 Oct 20.

PMID:
25327782
19.

Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region.

Craig ME, Jones TW, Silink M, Ping YJ.

J Diabetes Complications. 2007 Sep-Oct;21(5):280-7.

PMID:
17825751
Items per page

Supplemental Content

Write to the Help Desk